Shopping Cart
- Remove All
- Your shopping cart is currently empty
Etalocib (LY293111) is a novel diaryl ether carboxylic acid derivative, is a selective and potent inhibitor of the lipoxygenase pathway either via antagonism of the leukotriene B4 (LTB4) receptor or directly through 5'-lipoxygenase. It has antineoplastic activities.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $65 | In Stock | |
5 mg | $163 | In Stock | |
10 mg | $238 | In Stock | |
25 mg | $442 | In Stock | |
50 mg | $648 | In Stock | |
100 mg | $930 | In Stock | |
200 mg | $1,250 | In Stock | |
1 mL x 10 mM (in DMSO) | $203 | In Stock |
Description | Etalocib (LY293111) is a novel diaryl ether carboxylic acid derivative, is a selective and potent inhibitor of the lipoxygenase pathway either via antagonism of the leukotriene B4 (LTB4) receptor or directly through 5'-lipoxygenase. It has antineoplastic activities. |
Alias | VML295, LY293111 |
Molecular Weight | 544.6 |
Formula | C33H33FO6 |
Cas No. | 161172-51-6 |
Smiles | CCCc1c(OCCCOc2cc(O)c(cc2CC)-c2ccc(F)cc2)cccc1Oc1ccccc1C(O)=O |
Relative Density. | 1.215g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 100 mg/mL (183.62 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.